NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Navidea Biopharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2023 was 44.8 %, a 23.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 44.8 -13.5 -23.1% Sep 30, 2023
Q2 2023 45.9 -38.3 -45.5% Jun 30, 2023
Q1 2023 32.4 -106 -76.6% Mar 31, 2023
Q4 2022 41.3 -140 -77.3% Dec 31, 2022
Q3 2022 58.4 -136 -70% Sep 30, 2022
Q2 2022 84.3 -94.2 -52.8% Jun 30, 2022
Q1 2022 139 -15.2 -9.9% Mar 31, 2022
Q4 2021 182 +60.6 +50.1% Dec 31, 2021
Q3 2021 195 +89.1 +84.5% Sep 30, 2021
Q2 2021 179 +80 +81.2% Jun 30, 2021
Q1 2021 154 +50.7 +49.1% Mar 31, 2021
Q4 2020 121 +12.6 +11.6% Dec 31, 2020
Q3 2020 105 -25.2 -19.3% Sep 30, 2020
Q2 2020 98.5 -37.8 -27.7% Jun 30, 2020
Q1 2020 103 -27.5 -21% Mar 31, 2020
Q4 2019 108 -29 -21.1% Dec 31, 2019
Q3 2019 131 -12.6 -8.83% Sep 30, 2019
Q2 2019 136 -33 -19.5% Jun 30, 2019
Q1 2019 131 -52.4 -28.6% Mar 31, 2019
Q4 2018 137 -74.8 -35.2% Dec 31, 2018
Q3 2018 143 +74.3 +108% Sep 30, 2018
Q2 2018 169 +130 +336% Jun 30, 2018
Q1 2018 183 +159 +673% Mar 31, 2018
Q4 2017 212 +197 +1345% Dec 31, 2017
Q3 2017 68.9 +48.4 +236% Sep 30, 2017
Q2 2017 38.8 +5.11 +15.2% Jun 30, 2017
Q1 2017 23.7 -52.3 -68.8% Mar 31, 2017
Q4 2016 14.7 -164 -91.8% Dec 31, 2016
Q3 2016 20.5 -131 -86.4% Sep 30, 2016
Q2 2016 33.7 -106 -75.9% Jun 30, 2016
Q1 2016 76 -64.3 -45.8% Mar 31, 2016
Q4 2015 178 -72.4 -28.9% Dec 31, 2015
Q3 2015 151 -173 -53.4% Sep 30, 2015
Q2 2015 140 -323 -69.8% Jun 30, 2015
Q1 2015 140 -375 -72.8% Mar 31, 2015
Q4 2014 251 -196 -43.9% Dec 31, 2014
Q3 2014 325 -105 -24.4% Sep 30, 2014
Q2 2014 463 +195 +72.8% Jun 30, 2014
Q1 2014 516 +299 +137% Mar 31, 2014
Q4 2013 447 +173 +63% Dec 31, 2013
Q3 2013 430 +25.2 +6.24% Sep 30, 2013
Q2 2013 268 -315 -54.1% Jun 30, 2013
Q1 2013 217 -344 -61.3% Mar 31, 2013
Q4 2012 274 Dec 31, 2012
Q3 2012 404 Sep 30, 2012
Q2 2012 583 Jun 30, 2012
Q1 2012 561 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.